It’s too soon to say the flu season has peaked, but it’s at least possible it may have plateaued.
Late last year Oxitec debuted its first “mobile production unit” — a miniature factory designed to help expand its reach.
The official U.S. Olympic Committee’s Sports Medicine Division recruits a crew of volunteer doctors — as well as orthopedists, chiropractors, nurses, sports therapists, massage therapists, and more — every two years.
Dozens of doctors, medical ethicists, and lawyers are warning Congress that legislation to allow Americans with life-threatening conditions access to unapproved, experimental drugs risks harming patients’ health.
A government shutdown of the FDA, CDC and NIH will likely have widespread and long-lasting consequences for public health.
Luxturna, a gene therapy with a list price $850,000, is the latest flashpoint in the debate over how to afford innovative medicines.
With this week’s bellicose boasting about who has the bigger red button on his desk, an alert Thursday from the Centers for Disease Control and Prevention felt more than a bit on the nose.
Widespread screening for "scrutiny-dependent" cancers — those for which the harder you look the more you find, and the more of what you find is harmless — causes another problem, two leading cancer experts argue in a paper published on…
Here are three 2018 campaigns to watch to determine what American voters make of how health care policy is being shaped in Washington.
Some tiny technologies could lead to some big advances in neuroscience in 2018. Here's what we'll be paying attention to.
Additional Support Provided By:
